Novo

Danish pharmaceutical company

NOVO Nasdaq Copenhagen · home listing NVO NYSE ISIN DK0062498333 LEI 549300DAQ1CVT6CXN342
Follow Novo Weekly email: filings, results

Financials

Reported figures only · latest: fiscal 2026 DKK · IFRS
EPS, diluted -

Source: ESEF annual reports · latest filing